reports
Globus Medical completes acquisition of Nevro Corp.
Globus Medical completes acquisition of Nevro Corp. AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chron...
Globus Medical extends versatility of Advanced Materials Science™ ante...
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion (ALIF) surgery, andModulus™ ALIF Blades: An extension of the market-leading Modulus™ ALIF interbody spacer system. The COHERE ™ ALIF Spacer is the latest addition to...
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty a...
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in San Diego, Calif., from March 10-14, 2025. Join Globus at booth #2517 to learn about the comprehensive Globus Medical product portfolio across Spine, Trauma, and Joint Reconstruction procedures; Enabling Technolog...
Globus Medical to participate in the Canaccord Genuity 2025 Musculoske...
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference Monday, March 10, 2025 at 4:30 pm Pacific Time AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT. Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of...
Globus Medical Inc: 1 director
A director at Globus Medical Inc sold 7,500 shares at 78.680USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Globus Medical Reports Fourth Quarter and Full Year 2024 Results
Globus Medical Reports Fourth Quarter and Full Year 2024 Results AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024: Worldwide net sales were $657.3 million, an increase of 6.6% on an as-reported basis and an increase of 6.9% on a constant currency basisGAAP net income for the quarter was $26.5 millionGAAP diluted earnings per share (“EPS”) was $0.19 and non-GAAP diluted EPS was $0.84Non-GAAP ...
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for ...
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced they have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the bo...
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Re...
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2024 after the market close on Thursday, February 20, 2025. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Part...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
S&P 500 Testing Prior Breakout Level DeepSeek appears to have turned the chatbot market upside-down, putting pressure on AI-linked stocks. While the dust has yet to settle, the good news is that the selloff has been largely contained to these AI-linked stocks. The rest of the market did not seem to care; the equal-weighted S&P 500 was roughly flat yesterday. Additionally, market dynamics remain healthy, with Treasury yields, the U.S. dollar (DXY), and WTI crude oil continuing to move lower, and...
SYK STRYKER CORPORATION
GBX GREENBRIER COMPANIES INC.
TRN TRINITY INDUSTRIES INC.
MMSI MERIT MEDICAL SYSTEMS INC.
MDT MEDTRONIC PLC
ISRG INTUITIVE SURGICAL INC.
INGN INOGEN INC.
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
GMED GLOBUS MEDICAL INC CLASS A
CRY CRYOLIFE INC.
PEN PENUMBRA INC.
BSX. BELO SUN MINING CORP.
SIBN GAZPROM NEFT PJSC
GATX GATX CORPORATION
RAIL FREIGHTCAR AMERICA INC.
WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION
OFIX ORTHOFIX MEDICAL INC.
ECOR ELECTROCORE INC.
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year...
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results AUDUBON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2024. The company anticipates fourth quarter 2024 sales of approximately $657.0 million, an increase of 6.6 percent over the fourth quarter 2023 on an as-reported basis. Full year 2024 sales are expected to be approximately $2.52 billion, an increase of 60.6 percent over t...
Globus Medical Launches ExcelsiusHub™ Navigation System
Globus Medical Launches ExcelsiusHub™ Navigation System AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ExcelsiusHub™ navigation system. ExcelsiusHub™ joins the expansive ecosystem of Excelsius™ technologies and is designed to elevate the standard for freehand navigation. Freehand navigation provides surgeons with real-time visualization of instrument placement, to reduce the reliance on X-ray imaging during spine surgery. This also facilitates accurate place...
Globus Medical Reports Third Quarter 2024 Results
Globus Medical Reports Third Quarter 2024 Results AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024. Worldwide net sales were $625.7 million, an increase of 63.1%GAAP net income for the quarter was $51.8 millionGAAP diluted earnings per share (“EPS”) was $0.38 and non-GAAP diluted EPS was $0.83Non-GAAP adjusted EBITDA was $193.7 million, or 31.0% of net sales “Our third quarter results reflect the enduring strength of our business. ...
Globus Medical to Participate in Orthopedic Trauma Association Annual ...
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at booth #361 during OTA for product demonstrations of the PRECICE™ technologies and our full orthopedic trauma product portfolio. Special highlights include our most recent additions to the portfolio including TENSOR™ Suture Button, ANTHEM™ II Distal R...
Globus Medical Schedules Third Quarter Earnings Release and Conference...
Globus Medical Schedules Third Quarter Earnings Release and Conference Call AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference c...
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions AUDUBON, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announces the continued growth and expansion of its orthopedic trauma product portfolio. Globus has introduced several new system extensions so far in 2024 and received 510(k) clearance from the U.S. Food and Drug Administration for its first suture-based product, TENSOR™ Suture Button System. Newly launched, next-generation systems include ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Tro...
Globus Medical Launches ADIRA™ XLIF™ Plate System
Globus Medical Launches ADIRA™ XLIF™ Plate System AUDUBON, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ADIRA™ XLIF™ Plate System, the Company’s first product launch compatible across its expanded lateral interbody portfolio. “This launch represents an important milestone in our integration roadmap,” said David Hole, president of Spine at Globus Medical. “Through the system’s ability to be paired with our industry-leading Globus and NuVasive interbody spacers, ADIRA™...
Globus Medical Reports Second Quarter 2024 Results
Globus Medical Reports Second Quarter 2024 Results AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2024. Worldwide net sales were $629.7 million, an increase of 115.9% or 117.3% on a constant currency basisGAAP net income for the quarter was $31.8 millionGAAP diluted earnings per share (“EPS”) was $0.23 and non-GAAP diluted EPS was $0.75Non-GAAP adjusted EBITDA was $190.4 million, or 30.2% of net sales “I’m pleased with the quarterl...
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and AC...
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex™ with Total Knee Arthroplasty (TKA) application. This new robotic navigation platform joins the already best-in-class Excelsius™ ecosystem, designed to offer surgeons control, resection accuracy, and procedural flexibility in Total Knee Arthroplasty. ...
Globus Medical Schedules Second Quarter Earnings Release and Conferenc...
Globus Medical Schedules Second Quarter Earnings Release and Conference Call AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2024 after the market close on Tuesday, August 6, 2024. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call l...
Globus Medical Reports First Quarter 2024 Results
Globus Medical Reports First Quarter 2024 Results AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024. Worldwide net sales were $606.7 million, an increase of 119.3%, or 119.8% on a constant currency basisGAAP net loss for the quarter was $7.1 millionGAAP diluted earnings per share (“EPS”) was ($0.05) and non-GAAP diluted EPS was $0.72Non-GAAP adjusted EBITDA was $166.6 million, or 27.5% of net sales “Since the NuVasive merger closed in Se...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.